Patent · US Active

NS1-binding protein

US12281157B2 · kind B2 · utility

0Cited by

1References

17Claims

0Family size

Assignee

Fapon Biotech Inc. · CN

Inventors

Peng Cui · Suwon-si, KR
Zhiqiang He · Nanhu, CN
Yuan Meng · Rochester, US
Dongmei ZHONG · Dongguan, CN

Key dates

Filing date	Aug 26, 2019
Grant date	Apr 22, 2025
Priority date	—
Expiry date	Jan 25, 2040

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

Provided is an isolated binding protein including an antigen binding domain binding to an NS1 protein, and including specific heavy chain CDR and light chain CDR. The binding protein can specifically identify and bind to NS1, and has relatively high sensitivity and specificity, so as to detect dengue vims. Moreover, the binding protein does not need to be produced by injecting hybridoma cells into mouse peritoneal cavity, while simplifying production, thus stabilizing antibody functionality.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.